Self-management Intervention for Reducing Epilepsy Burden Among Ugandans With Epilepsy.

Mean change in cumulative past 24-week seizure frequency (24 weeks prior to study baseline compared to the 24-week follow-up,Mean change from baseline to 24 weeks in QOL. QOL will be assessed by the 31-item Quality of Life in Epilepsy (QOLIE-31) questionnaire

The goal of this clinical trial is to assess the efficacy of self management intervention for
 reducing epilepsy burden among Ugandans with epilepsy (SMART- U) vs. enhanced treatment as
 usual (eTAU) via an RCT in adults with epilepsy. The main question[s] it aims to answer are:
 
 - What is the efficacy of SMART - Uganda (SMART-U) versus enhanced treatment as usual
 (eTAU) among PWE?
 
 - How does short message service (SMS) delivered by mobile phone text validate
 self-reported seizure occurrence? Participants will be randomly (1:1 basis) assigned to
 receive either SMART-U (N=94) or eTAU (N=94) using block randomization.
 
 SMART-U will consist of 2 main components: a 12-week intensive group format stage and a
 12-week remotely accessed telephone follow-up stage. Individuals randomized to eTAU will
 continue in their usual care supplemented by written materials on epilepsy in their preferred
 language and tailored to the reading level of most patients at the clinic.
 
 If there is a comparison group: We will compare the mean change in seizure frequency and
 quality of life from baseline and 24 weeks of follow up.